Sylvie Veiga

810 citations

16 papers · 647 indexed · h-index 11

Impact in

Cellular and Molecular Neuroscience top 5%
- Neurotransmitter Receptor Influence on Behavior
- Neuroscience and Neuropharmacology Research
Biological Psychiatry top 10%
- Tryptophan and brain disorders

Papers in

Cellular and Molecular Neuroscience 16
- Neurotransmitter Receptor Influence on Behavior 14
- Neuroscience and Neuropharmacology Research 6
Molecular Biology 12
- Receptor Mechanisms and Signaling 11
- Nicotinic Acetylcholine Receptors Study 2
- Ion channel regulation and function 1

Co-authors: Mauricette Brocco Alain P. Gobert Mark J. Millan Valérie Audinot Robert D. Schreiber Sylvie Girardon Anne Dekeyne Rudy Schreiber
Journals: Journal of Pharmacology and Experimental Therapeutics (5 papers)Behavioural Pharmacology (4 papers)European Journal of Pharmacology (3 papers)International Journal of Molecular Sciences (1 paper)European Neuropsychopharmacology (1 paper)
Partner nations: France Netherlands Sweden

In The Last Decade

Sylvie Veiga

16 papers receiving 621 citations

Peers

Countries citing papers authored by Sylvie Veiga

Since Specialization

Citations

This map shows the geographic impact of Sylvie Veiga's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sylvie Veiga with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sylvie Veiga more than expected).

Fields of papers citing papers by Sylvie Veiga

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sylvie Veiga. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sylvie Veiga. The network helps show where Sylvie Veiga may publish in the future.

Co-authors

The 25 scholars most cited alongside Sylvie Veiga, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Sylvie Veiga Line = papers co-authored together Sylvie Veiga links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

#	Work
1	Trace Amine-Associated Receptor 1 Contributes to Diverse Functional Actions of O-Phenyl-Iodotyramine in Mice but Not to the Effects of Monoamine-Based Antidepressants International Journal of Molecular Sciences ·Ioannis Mantas, Mark J. Millan, Benjamin Di Cara, Lucianne Groenink, Sylvie Veiga, Laetitia Cistarelli, Mauricette Brocco, Marc Bertrand, Per Svenningsson, Xiaoqun Zhang	2021	10
2	Cellular and behavioural profile of the novel, selective neurokinin1 receptor antagonist, vestipitant: A comparison to other agents European Neuropsychopharmacology ·Mauricette Brocco, Anne Dekeyne, Clotilde Mannoury la Cour, Manuelle Touzard, Sylvie Girardon, Sylvie Veiga, Guillaume De Nanteuil, Trynke R. deJong, Berend Olivier, Mark J. Millan	2008	26
3	S33138 [N-[4-[2-[(3 aS,9 bR)-8-Cyano-1,3 a,4,9 b-tetrahydro[1]-benzopyrano[3,4-c]pyrrol-2(3 H)-yl)-ethyl]phenylacetamide], a Preferential Dopamine D3 versus D2 Receptor Antagonist and Potential Antipsychotic Agent. II. A Neurochemical, Electrophysiological and Behavioral Characterization in Vivo Journal of Pharmacology and Experimental Therapeutics ·Mark J. Millan, Per Svenningsson, Charles R. Ashby, Michael P. Hill, Martin Egeland, Anne Dekeyne, Mauricette Brocco, Benjamin Di Cara, Franćoise Lejeune, Nitza Thomasson, Carmen Muñoz, Elisabeth Mocaër, Alan R. Crossman, Laetitia Cistarelli, Sylvie Girardon, Loretta Iob, Sylvie Veiga, Alain P. Gobert	2007	34
4	Blockade of serotonin 5-HT 1B and 5-HT 2A receptors suppresses the induction of locomotor activity by 5-HT reuptake inhibitors, citalopram and fluvoxamine, in NMRI mice exposed to a novel environment: a comparison to other 5-HT receptor subtypes Psychopharmacology ·Mark J. Millan, Sylvie Veiga, Sylvie Girardon, Mauricette Brocco	2003	42
5	Induction of hyperlocomotion in mice exposed to a novel environment by inhibition of serotonin reuptake Pharmacology Biochemistry and Behavior ·Mauricette Brocco, Anne Dekeyne, Sylvie Veiga, Sylvie Girardon, Mark J. Millan	2002	103
6	Induction of Spontaneous Tail-Flicks in Rats by Blockade of Transmission at N-Methyl-d-Aspartate Receptors: Roles of Multiple Monoaminergic Receptors in Relation to the Actions of Antipsychotic Agents Journal of Pharmacology and Experimental Therapeutics ·Mark J. Millan, Alain P. Gobert, K Bervoets, Jean‐Michel Rivet, Sylvie Veiga, Mauricette Brocco	2000	3
7	Blockade of NMDA receptors in the nucleus accumbens elicits spontaneous tail-flicks in rats European Journal of Pharmacology ·Mark J. Millan, Valérie Audinot, Prisca Honoré, K Bervoets, Sylvie Veiga, Mauricette Brocco	2000	14
8	WAY 100,635 enhances both the `antidepressant' actions of duloxetine and its influence on dialysate levels of serotonin in frontal cortex European Journal of Pharmacology ·Mark J. Millan, Mauricette Brocco, Sylvie Veiga, Laetitia Cistarelli, Christophe Melon, Alain P. Gobert	1998	35
9	ACTIONS OF SELECTIVE ANTAGONISTS AT SEROTONIN (5-HT)2A, 5-HT2B AND 5-HT2C RECEPTORS IN RODENT MODELS OF POTENTIAL ANXIOLYTIC PROPERTIES Behavioural Pharmacology ·Mauricette Brocco, Anne Dekeyne, B. Denorme, S. Monneyron, H. Gressier, Sylvie Veiga, Mark J. Millan	1998	4
10	DISCRIMINATIVE STIMULUS (DS) PROPERTIES OF THE NOVEL AND POTENT SEROTONIN (5-HT)2C RECEPTOR AGONIST, RO 60???0175, IN RATS Behavioural Pharmacology ·Anne Dekeyne, Mauricette Brocco, Sylvie Girardon, S. Monneyron, Sylvie Veiga, Mark J. Millan	1998	1
11	DISCRIMINATIVE STIMULUS (DS) PROPERTIES OF THE NOVEL AND POTENT SEROTONIN (5-HT)2C RECEPTOR AGONIST, RO 60–0175, IN RATS Behavioural Pharmacology ·Anne Dekeyne, Mauricette Brocco, Sylvie Girardon, S. Monneyron, Sylvie Veiga, Mark J. Millan	1998	1
12	ACTIONS OF SELECTIVE ANTAGONISTS AT SEROTONIN (5-HT)2A, 5-HT2B AND 5-HT2C RECEPTORS IN RODENT MODELS OF POTENTIAL ANXIOLYTIC PROPERTIES Behavioural Pharmacology ·Mauricette Brocco, Anne Dekeyne, B. Denorme, S. Monneyron, H. Gressier, Sylvie Veiga, Mark J. Millan	1998	3
13	S 15535, A Novel Benzodioxopiperazine Ligand of Serotonin (5-HT)1A Receptors: II. Modulation of Hippocampal Serotonin Release in Relation to Potential Anxiolytic Properties Journal of Pharmacology and Experimental Therapeutics ·Mark J. Millan, Stephan Hjorth, R. Samanin, Rudy Schreiber, Robert Jaffard, Brigitte De Ladonchamps, Sylvie Veiga, Bertrand Goument, Jean-Louis Péglion, Michael Spedding, Mauricette Brocco	1997	62
14	(1-(2,5-dimethoxy-4 iodophenyl)-2-aminopropane)-induced head-twitches in the rat are mediated by 5-hydroxytryptamine (5-HT) 2A receptors: modulation by novel 5-HT2A/2C antagonists, D1 antagonists and 5-HT1A agonists. Journal of Pharmacology and Experimental Therapeutics ·Robert D. Schreiber, Mauricette Brocco, Valérie Audinot, Alain P. Gobert, Sylvie Veiga, Mark J. Millan	1995	266
15	The potent activity of the 5-HT1A receptor agonists, S 14506 and S 14671, in the rat forced swim test is blocked by novel 5-HT1A receptor antagonists European Journal of Pharmacology ·Rudy Schreiber, Mauricette Brocco, Alain P. Gobert, Sylvie Veiga, Mark J. Millan	1994	21
16	5-HT1A receptors and the tail-flick response. VI. Intrinsic alpha 1A-adrenoceptor antagonist properties can mask the actions of 5-HT1A receptor agonists in the spontaneous tail-flick paradigm. Journal of Pharmacology and Experimental Therapeutics ·M J Millan, Jean‐Michel Rivet, Alain P. Gobert, Hervé Canton, Sylvie Veiga, K Bervoets	1994	22

About Sylvie Veiga

Sylvie Veiga is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology, Social Psychology, Pharmacology and Physiology, having authored 16 papers that have together received 647 indexed citations. Recurring topics across this work include Neurotransmitter Receptor Influence on Behavior (14 papers), Receptor Mechanisms and Signaling (11 papers), Neuroscience and Neuropharmacology Research (6 papers), Pain Mechanisms and Treatments (3 papers), Neuroendocrine regulation and behavior (3 papers), Treatment of Major Depression (2 papers), Nicotinic Acetylcholine Receptors Study (2 papers) and Ion channel regulation and function (1 paper). The work is most often cited by research in Cellular and Molecular Neuroscience (492 citations), Biological Psychiatry (51 citations), Behavioral Neuroscience (51 citations), Clinical Psychology (101 citations) and Social Psychology (91 citations). Sylvie Veiga has collaborated with scholars based in France, Netherlands and Sweden. Frequent co-authors include Mauricette Brocco, Alain P. Gobert, Mark J. Millan, Valérie Audinot, Mark J. Millan, Robert D. Schreiber, Sylvie Girardon, Anne Dekeyne, Rudy Schreiber and Laetitia Cistarelli. Their work appears in journals such as Journal of Pharmacology and Experimental Therapeutics, Behavioural Pharmacology, European Journal of Pharmacology, International Journal of Molecular Sciences and European Neuropsychopharmacology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact